SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: Jay Lowe who wrote (230)5/20/1998 8:46:00 AM
From: John S. Baker  Read Replies (1) | Respond to of 586
 
Burn rate: In other words, about 9 months from that report. Just b-a-r-e-l-y enough time to get the FDA approval on use of the Column for RA. It could be worse.



To: Jay Lowe who wrote (230)5/20/1998 4:59:00 PM
From: muddphudd  Read Replies (1) | Respond to of 586
 
The 2.5 M burn rate is quarterly or annually?



To: Jay Lowe who wrote (230)5/29/1998 8:29:00 AM
From: Arthur Radley  Read Replies (1) | Respond to of 586
 
Morning Jay,
Just came across CYPB and it seems like an interesting stock with some upside potential in the near future. I like it when the FDA gets involved the way they are.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News